Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
2.600
+0.430 (19.82%)
Feb 21, 2025, 4:00 PM EST - Market closed

Acelyrin Statistics

Total Valuation

Acelyrin has a market cap or net worth of $260.85 million. The enterprise value is -$294.14 million.

Market Cap 260.85M
Enterprise Value -294.14M

Important Dates

The next estimated earnings date is Thursday, March 27, 2025, after market close.

Earnings Date Mar 27, 2025
Ex-Dividend Date n/a

Share Statistics

Acelyrin has 100.33 million shares outstanding. The number of shares has increased by 112.80% in one year.

Current Share Class 100.33M
Shares Outstanding 100.33M
Shares Change (YoY) +112.80%
Shares Change (QoQ) +0.68%
Owned by Insiders (%) 3.86%
Owned by Institutions (%) 71.01%
Float 72.21M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.49
P/TBV Ratio 0.49
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 7.15, with a Debt / Equity ratio of 0.01.

Current Ratio 7.15
Quick Ratio 7.10
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -41.95% and return on invested capital (ROIC) is -36.76%.

Return on Equity (ROE) -41.95%
Return on Assets (ROA) -32.89%
Return on Invested Capital (ROIC) -36.76%
Return on Capital Employed (ROCE) -69.80%
Revenue Per Employee n/a
Profits Per Employee -$1.96M
Employee Count 135
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -65.97% in the last 52 weeks.

Beta (5Y) n/a
52-Week Price Change -65.97%
50-Day Moving Average 2.56
200-Day Moving Average 4.40
Relative Strength Index (RSI) 63.62
Average Volume (20 Days) 3,224,683

Short Selling Information

The latest short interest is 5.87 million, so 5.85% of the outstanding shares have been sold short.

Short Interest 5.87M
Short Previous Month 6.53M
Short % of Shares Out 5.85%
Short % of Float 8.13%
Short Ratio (days to cover) 3.44

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -373.34M
Pretax Income -240.16M
Net Income -264.41M
EBITDA -373.01M
EBIT -373.34M
Earnings Per Share (EPS) -$2.68
Full Income Statement

Balance Sheet

The company has $562.37 million in cash and $7.38 million in debt, giving a net cash position of $554.99 million or $5.53 per share.

Cash & Cash Equivalents 562.37M
Total Debt 7.38M
Net Cash 554.99M
Net Cash Per Share $5.53
Equity (Book Value) 528.28M
Book Value Per Share 5.29
Working Capital 513.12M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$255.97 million and capital expenditures -$1.26 million, giving a free cash flow of -$257.23 million.

Operating Cash Flow -255.97M
Capital Expenditures -1.26M
Free Cash Flow -257.23M
FCF Per Share -$2.56
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Acelyrin does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -112.80%
Shareholder Yield -112.80%
Earnings Yield -101.36%
FCF Yield -98.61%

Analyst Forecast

The average price target for Acelyrin is $9.60, which is 269.23% higher than the current price. The consensus rating is "Hold".

Price Target $9.60
Price Target Difference 269.23%
Analyst Consensus Hold
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1